Biotech with Deep Pipeline, ‘Abundant’ Upcoming Catalysts Named Top Pick
April 11, 2018 at 04:00 AM EDT
Source: Streetwise Reports 04/11/2018 Douglas Loe, an analyst with Echelon Wealth Partners, made the case for why this biopharmaceutical company merits this status. In an April 3, 2018 research note, analyst Douglas Loe reported that [...]
